Trading Halt Request Solagran Limited (Company) hereby requests a trading halt pursuant to ASX listing rule 17.1 pending an announcement. The announcement relates to the status of the pharmaceutical wholesale licence for the Company's Russian subsidiary, Solagran Son. The announcement will be released to the market prior to the commencement of trading on Friday February 5 2010 upon which the trading halt will cease. The Company is not aware of any reason why the trading halt should not be granted.
BPO Price at posting:
3.5¢ Sentiment: None Disclosure: Held